Teja Kalidindi

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 4

Top Topics

Transcription Factor

Brain Metastases

Prostate Cancer

Top Venues

Molecular cancer research : MCR

Proceedings of the National Academy of Sciences of the United States of America

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Patricia Gonzalez Periche, Jacky Lin, Naga V S D K Bhupathiraju, Teja Kalidindi, Delissa S Johnson, Nagavarakishore Pillarsetty, David R Mootoo
Targeting Carbohydrate Mimetics of Tetrahydrofuran-Containing Acetogenins to Prostate Cancer. Molecules (Basel, Switzerland) 28 (7) (2023)
Sahil Sharma, Suhasini Joshi, Teja Kalidindi, Chander S Digwal, Palak Panchal, Sang-Gyu Lee, Pat Zanzonico, Naga Vara Kishore Pillarsetty, Gabriela Chiosis
Unraveling the Mechanism of Epichaperome Modulation by Zelavespib: Biochemical Insights on Target Occupancy and Extended Residence Time at the Site of Action. Biomedicines 11 (10) (2023)
Claire M Storey, Mohamed Altai, Mesude Bicak, Darren R Veach, Katharina Lückerath, Gabriel Adrian, Michael R McDevitt, Teja Kalidindi, Julie E Park, Ken Herrmann, Diane S Abou, Wahed Zedan, Norbert Peekhaus, Robert J Klein, Robert Damoiseaux, Steven M Larson, Hans G Lilja, Daniel L J Thorek, David Ulmert
Quantitative In Vivo Imaging of the Androgen Receptor Axis Reveals Degree of Prostate Cancer Radiotherapy Response. Molecular cancer research : MCR (2023)
Mesude Bicak, Katharina Lückerath, Teja Kalidindi, Michael E Phelps, Sven-Erik Strand, Michael J Morris, Caius G Radu, Robert Damoiseaux, Mari T Peltola, Norbert Peekhaus, Austin Ho, Darren R Veach, Ann-Christin Malmborg Hager, Steven M Larson, Hans G Lilja, Michael R McDevitt, Robert J Klein, David Ulmert
Genetic signature of prostate cancer mouse models resistant to optimized hK2 targeted α-particle therapy. Proceedings of the National Academy of Sciences of the United States of America 117 (26) (2020)